R&G PharmaStudies Co., Ltd. (SHE:301333)
China · Delayed Price · Currency is CNY 66.28
+0.49 (0.74%)
At close: Mar 5, 2026
R&G PharmaStudies Employees
R&G PharmaStudies had 2,208 employees as of December 31, 2024. The number of employees increased by 166 or 8.13% compared to the previous year.
Employees
2,208
Change (1Y)
166
Growth (1Y)
8.13%
Revenue / Employee
357.54K CNY
Profits / Employee
68.56K CNY
Market Cap
6.30B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2,208 | 166 | 8.13% |
| Dec 31, 2023 | 2,042 | 116 | 6.02% |
| Jan 1, 2023 | 1,926 | 1,298 | 206.69% |
| Dec 31, 2015 | 628 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Xiangxue Pharmaceutical | 2,769 |
| Novogene | 2,190 |
| GemPharmatech | 1,578 |
| Kexing Biopharm | 971 |
| Wuhan Keqian Biology Co.,Ltd | 922 |
| Lifecome Biochemistry | 898 |
| Shenzhen Weiguang Biological Products | 859 |
| Jiangsu Aidea Pharmaceutical Group | 683 |